Cargando...
High-dose intravenous human immunoglobulin in polymyositis resistant to treatment.
Two patients were treated with treatment-resistant polymyositis with intravenous immunoglobulin over four days at a dose of 0.4 g/kg/day. Clinical recovery followed within two months. Serum creatine kinase (CK) activity decreased to normal, and a clear improvement in muscle strength was observed. On...
Gardado en:
| Publicado en: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
1992
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC488936/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1372349/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.55.1.60 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|